Magiorakos A. P.,Srinivasan A.,Carey R. B.,Carmeli Y.,Falagas M. E.,Giske C. G.,Perl T. M. .2012 .Multidrug-resistant, extensively drug-resistant and pan-resistant bacteria: an urgent threat to one and all. Clinical Microbiology and Infection, 18(3) : 268-281.
Sandes V.,Figueras A.,Lima E.C. .2024 .Pharmacovigilance Strategies to Address Resistance to AB and Inappropriate Use-A Narrative Review. AB, 13 : .
De Gregorio E.,Di Pierro F.,Indiveri F.,Di Rosa F. .2016 .Antibiotic-associated diarrhea: Epidemiology, microbiology, and management strategies. World journal of gastroenterology, 22(15) : 3573.
Lazaridou E.,Papapetropoulou M.,Falagas M. E. .2015 .Underreporting of adverse drug reactions: a continuing challenge. Therapeutic advances in drug safety, 6(1) : 1-11.
Benson K.,Ryan P.,Lippi G. .2018 .Real-world data and pharmacovigilance: opportunities and challenges. Clinical Pharmacology & Therapeutics, 103(3) : 326-330.
Chen Y.,Zeng D.,Liu Y.,X. Y. .2018 .Application of machine learning in pharmacovigilance: a systematic review. Drug Safety, 41(1) : 1-17.
World Health Organization (WHO). ,May 19 .2020 .. Strategy Update. document (WHA73, : .
World Health Organization. .2020 .Antibiotic use during the COVID-19 pandemic: global guidance. World Health Organization., : .
. .Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. , : .
Tacconelli E.,Carrara E.,Luca V.,Pompei F.,Ricciardi G.,Mensa S. .2020 .Antibiotic consumption in 2020: a global challenge in the COVID-19 era. Clinical Microbiology and Infection, 26(4) : 459-460.
World Health Organization. .2022 .Antimicrobial resistance. World Health Organization., : .
. .Inadequate use of AB in the covid-19 era: effectiveness of antibiotic therapy bmcinfectdis. , : .
Lazaridou E.,Papapetropoulou M.,Falagas M. E. .2015 .Underreporting of adverse drug reactions: a continuing challenge. Therapeutic advances in drug safety, 6(1) : 1-11.
Benson K.,Ryan P.,Lippi G. .2018 .Real-world data and pharmacovigilance: opportunities and challenges. Clinical Pharmacology & Therapeutics, 103(3) : 326-330.
Lepak N. J. .2018 .Antimicrobial prescribing patterns in primary care: A systematic review. JAMA Internal Medicine, 178(7) : 940-949.
World Health Organization. .2020 .Coronavirus disease (COVID-19) pandemic. , : .
Gaudreault F. .2020 .Azithromycin for the treatment of COVID-19: A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy, 75(9) : 2653-2662.
Wang M. .2020 .Remdesivir and chloroquine potentially inhibit the novel coronavirus (2019- nCoV) through binding to its RNA-dependent RNA polymerase. Cell Research, 30(3) : 269-274.
Patel N.,Desai N. .2018 .Adverse drug reactions: An overview. Indian Journal of Pharmaceutical Education and Research, 52(2) : 118-127.
Lippi G. .2020 .The COVID-19 pandemic and adverse drug reactions: A call for action. Clinical Pharmacology & Therapeutics, 107(5) : 1013-1015.